Novo Nordisk A/S (NONOF)
NONOF Stock Price Chart
Explore Novo Nordisk A/S interactive price chart. Choose custom timeframes to analyze NONOF price movements and trends.
NONOF Company Profile
Discover essential business fundamentals and corporate details for Novo Nordisk A/S (NONOF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 May 2010
Employees
77.41K
Website
https://www.novonordisk.comCEO
Lars Fruergaard Jorgensen
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
NONOF Financial Timeline
Browse a chronological timeline of Novo Nordisk A/S corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 5 Nov 2025
Revenue estimate is $12.15B.
Earnings released on 6 Aug 2025
EPS came in at $0.94 surpassing the estimated $0.94 by +0.53%, while revenue for the quarter reached $12.13B , missing expectations by -1.39%.
Dividend declared on 6 Aug 2025
A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 19 Aug 2025.
Earnings released on 7 May 2025
EPS came in at $0.96 surpassing the estimated $0.89 by +8.59%, while revenue for the quarter reached $11.49B , missing expectations by -3.89%.
Earnings released on 5 Feb 2025
EPS came in at $0.88 surpassing the estimated $0.83 by +5.93%, while revenue for the quarter reached $11.86B , beating expectations by +6.92%.
Earnings released on 6 Nov 2024
EPS came in at $0.92 surpassing the estimated $0.90 by +2.46%, while revenue for the quarter reached $10.68B , missing expectations by -0.75%.
Earnings released on 7 Aug 2024
EPS came in at $0.65 falling short of the estimated $0.70 by -7.04%, while revenue for the quarter reached $9.80B , missing expectations by -0.40%.
Dividend declared on 7 Aug 2024
A dividend of $0.52 per share was announced, adjusted to $0.52. The dividend was paid on 19 Aug 2024.
Earnings released on 2 May 2024
EPS came in at $0.82 surpassing the estimated $0.75 by +8.22%, while revenue for the quarter reached $9.38B , beating expectations by +2.53%.
Earnings released on 7 Mar 2024
EPS came in at $0.72 surpassing the estimated $0.68 by +6.78%, while revenue for the quarter reached $9.72B , beating expectations by +4.86%.
Dividend declared on 5 Feb 2024
A dividend of $1.14 per share was announced, adjusted to $1.14. The dividend was paid on 1 Apr 2025.
Dividend declared on 31 Jan 2024
A dividend of $0.93 per share was announced, adjusted to $0.93. The dividend was paid on 26 Mar 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.71 surpassing the estimated $0.68 by +3.97%, while revenue for the quarter reached $8.29B , beating expectations by +1.44%.
Stock split effective on 13 Sept 2023
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 10 Aug 2023
A dividend of $0.88 per share was announced, adjusted to $0.44. The dividend was paid on 22 Aug 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.63 falling short of the estimated $0.67 by -5.83%, while revenue for the quarter reached $7.93B , missing expectations by -2.11%.
Earnings released on 26 Jun 2023
EPS came in at $0.64 surpassing the estimated $0.61 by +4.23%, while revenue for the quarter reached $7.78B , beating expectations by +2.72%.
Dividend declared on 22 Mar 2023
A dividend of $1.18 per share was announced, adjusted to $0.59. The dividend was paid on 28 Mar 2023.
Earnings released on 1 Feb 2023
EPS came in at $0.88 surpassing the estimated $0.85 by +3.79%, while revenue for the quarter reached $6.95B , beating expectations by +2.42%.
Earnings released on 2 Nov 2022
EPS came in at $0.84 surpassing the estimated $0.82 by +2.19%, while revenue for the quarter reached $5.97B , beating expectations by +2.13%.
Dividend declared on 11 Aug 2022
A dividend of $0.59 per share was announced, adjusted to $0.30. The dividend was paid on 16 Aug 2022.
Earnings released on 3 Aug 2022
EPS came in at $0.80 falling short of the estimated $0.82 by -2.20%, while revenue for the quarter reached $5.79B , missing expectations by -0.80%.
Earnings released on 29 Apr 2022
EPS came in at $0.88 surpassing the estimated $0.81 by +9.05%, while revenue for the quarter reached $6.25B , beating expectations by +5.96%.
Earnings released on 2 Feb 2022
EPS came in at $0.73 surpassing the estimated $0.72 by +1.25%, while revenue for the quarter reached $5.84B , beating expectations by +0.80%.
Dividend declared on 2 Feb 2022
A dividend of $1.02 per share was announced, adjusted to $0.51. The dividend was paid on 29 Mar 2022.
Earnings released on 3 Nov 2021
EPS came in at $0.82 surpassing the estimated $0.78 by +5.40%, while revenue for the quarter reached $5.56B .
Dividend declared on 16 Aug 2021
A dividend of $0.55 per share was announced, adjusted to $0.28. The dividend was paid on 18 Aug 2021.
Earnings released on 4 Aug 2021
EPS came in at $0.83 surpassing the estimated $0.76 by +10.17%, while revenue for the quarter reached $5.27B .
Earnings released on 5 May 2021
EPS came in at $0.88 surpassing the estimated $0.82 by +7.28%, while revenue for the quarter reached $5.34B .
Dividend declared on 26 Mar 2021
A dividend of $0.93 per share was announced, adjusted to $0.46. The dividend was paid on 30 Mar 2021.
Earnings released on 3 Feb 2021
EPS came in at $0.65 surpassing the estimated $0.63 by +2.86%, while revenue for the quarter reached $5.28B .
Earnings released on 30 Oct 2020
EPS came in at $0.69 falling short of the estimated $0.70 by -1.00%, while revenue for the quarter reached $4.87B .
NONOF Stock Performance
Access detailed NONOF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.